The usual concern with regards to treatment with IGF-1 has historically been hypoglycaemia, however in the trials done so far it has not always occurred and had been lessened when administered with mealsit was also usually connected to an appearance in a loss of appetite [264, 286]
This leaves a stable, dry compound that is suitable for research applications
By deploying an oral delivery mechanism, investigators can map localized enteric and adipocyte enzymatic inhibition against wider systemic metabolic adaptation loops
Once your B12 levels are back to normal, or if a change in your diet gives your body all the B12 it needs, you may be asked to stop taking these tablets
They reduce appetite, improve blood sugar control, and enhance metabolic health
B-12 - contraindicated in Lebers disease (optic atrophy)